InnovAge
INNV
$6.01
Share price
-1.06%
Change (1 day)
39.67%
Change (1 year)
Categories
InnovAge (INNV) - Total debt
Total debt on the balance sheet as of March 2023 : $0.11 B
According to InnovAge's latest financial reports the company's total debt is $0.11 B. A company’s total debt is the sum of all current and non-current debts.
InnovAge - Total debt on balance sheet (from 2020 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-06-30 | $84.81 M | 2.64% |
| 2021-06-30 | $82.63 M | -62.09% |
| 2020-06-30 | $0.21 B | 11.9% |
| 2019-06-30 | $0.19 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $30.74 B | 27,519.23% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | $0.17 M | -99.84% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $3.36 M | -96.97% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.55 B | 2,197.37% | 🇮🇪 Ireland |